Treatment of antibody-mediated pure red-cell aplasia with high-dose intravenous gamma globulin.
D001327:Autoimmune Diseases / Q000628:therapy*; D004921:Erythropoietin / Q000494:pharmacology; D005260:Female; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D007116:Immunization, Passive / Q000379:methods*; D007074:Immunoglobulin G / Q000008:administration & dosage* / Q000032:analysis / Q000276:immunology; D016756:Immunoglobulins, Intravenous; D007223:Infant; D007275:Injections, Intravenous; D012010:Red-Cell Aplasia, Pure / Q000628:therapy*
D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D004921:Erythropoietin